Randomized phase II study of temozolomide given every 8 hours or daily with either interferon alfa-2b or thalidomide in metastatic malignant melanoma (Q40578614)
Jump to navigation
Jump to search
scientific article published on July 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized phase II study of temozolomide given every 8 hours or daily with either interferon alfa-2b or thalidomide in metastatic malignant melanoma |
scientific article published on July 2003 |
Statements
1 reference
Randomized phase II study of temozolomide given every 8 hours or daily with either interferon alfa-2b or thalidomide in metastatic malignant melanoma (English)
1 reference
1 reference
S Danson
1 reference
A Clamp
1 reference
M Ranson
1 reference
J Hodgetts
1 reference
L Lomax
1 reference
L Ashcroft
1 reference
N Thatcher
1 reference
M R Middleton
1 reference
1 July 2003
1 reference
1 reference
Identifiers
1 reference